Уноси

• Minocycline as heart conditioning agent in experimental type 2 diabetes mellitus-an antibacterial drug in heart protection. (2022-02)

  Sobot NM, Sobot TS, Jeremic JN, Bolevich SB, Bolevich SS, Mitrovic SLj, Fisenko VP, Inic SG, Milojevic Samanovic AD, Rankovic MR, Srejović IM, Zivkovic VI, Jakovljevic VLj, Minocycline as heart conditioning agent in experimental type 2 diabetes mellitus-an antibacterial drug in heart protection., NAUNYN-SCHMIEDEBERG`S ARCHIVES OF PHARMACOLOGY, No. 395, pp. 429 - 444, Feb, 2022

• Protective power of minocycline as heart conditioning agent in experimental type 2 diabetes mellitus. (2021-09)

  Srejovic IM, Sobot NM, Sobot TS, Jeremic JN, Bolevich SB, Bolevich SS, Mitrovic SLj, Milojevic Samanovic AD, Rankovic MR, Zivkovic VI, Jakovljevic VLj, Protective power of minocycline as heart conditioning agent in experimental type 2 diabetes mellitus., 7th meeting of the European Section and 8th meeting of the North American Section of the International Academy of Cardiovascular Sciences (IACS) "Cardioprotection and Cardiometabolic Diseases: From Bench to Beside", Banja Luka, 2021. Abstract book., Sep, 2021